Specifically, it notes that BPC 157 (10 g/mL three times a week i.p.) significantly improved total body weight in the C26 colon adenocarcinoma-induced cancer cachexia mouse model as compared to that of the control group of animals
This is where your handling protocol becomes the single most important factor in the success of your research
Timestamps 00:00 Cold open: 200 years of menopause medicine 03:23 Welcome and roadmap 04:20 The HPG axis, follicles, and the FSH lag 09:11 STRAW+10 staging and the timing of perimenopause 13:47 Austin: the 49-year-old with a hormone panel 20:00 Loraine: the OB-GYN workup 28:00 Symptom attribution: what menopause actually causes 33:46 Austin: the all-estrogen patient 37:58 VMS duration and the KNDy mechanism (Avis, SKYLIGHT) 43:53 Austin: who actually gets fezolinetant 47:22 The WHI 24-year correction (Manson, Chlebowski, Boardman) 01:00:15 Modern prescribing today 01:06:52 Where the menopause-content space gets it right and wrong 01:11:50 Testosterone, compounded bioidenticals, and DUTCH panels 01:24:13 Takeaways What we cover The HPG axis and the estrogen shield: what is happening across the 35-year reproductive era and what changes at perimenopause
This is worth holding onto as we move to the central nervous system, where the bar for regeneration is far higher and where much of what is reported for both peptides is more accurately described as neuroprotection or remodeling rather than true regrowth of lost circuits
Raised IGF-1: levels are checked periodically, and the dose is adjusted if they climb too high
We also see patients whove driven from Greeneville, Jonesborough, and Mountain City because finding a provider who takes peptide therapy seriously, under real medical oversight, isnt always easy in East Tennessee
